News List

Novartis‘s Multiple sclerosis Innovative drug approved

Recently, US FDA announced approved the listing of Mayzent (siponimod) developed by Novartis, for the treatment of recur

Highly efficient trifluoromethylation and [18F]trifluoromethylation

Jichang Xiao, researcher at Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, has created a new trif

Redox neutral [4+1] cyclic reaction based on C-F fracture

Recently, Professor Feng Chao of the Institute of Advanced Synthesis of Nanjing University of Technology and Professor R

FDA accelerates approval of no-limit cancer targeting therapy for the treatment of NTRK fusion tumors

Recently, LOXO Oncology and Bayer jointly announced that the FDA has accelerated the approval of a co-developed VITRAKVI

FDA approves new mechanism for listing new anti-influenza drugs

Today, the US FDA announced the approval of the new anti-influenza drug Xofluza (baloxavir marboxil), jointly developed

FDA grants Relacorilant the qualification for orphan drugs for pancreatic cancer

Pancreatic cancer is the fourth leading cause of cancer-related deaths with a 5-year survival rate of 5%. In the United

For the first time, scientists have discovered fluorine in natural conditions

Fluorine is the most reactive chemical element. That is why it is not found in nature in its elemental form, but only in

Fluorinated antimalarial drug tafenoquine (Krintafel) approved by the US FDA

Recently, British pharmaceutical giant GlaxoSmithKline (GSK) announced that the fluorogenic anti-malarial drug tefenoqui

Sanofi is approved the listing of rare disease drugs in China

Sanofi is approved in China for the treatment of a new drug for relapsing multiple sclerosis, Obajie (Terifluide tablets

Why can fluorine-substituted conjugated polymers improve the efficiency of organic solar cells?

Today, with the increasing consumption of energy, research on solar cells has attracted more and more attention. Compare